# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-150803
Filing Date
2018-05-03
Accepted
2018-05-03 16:08:12
Documents
94
Period of Report
2018-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d331981d10q.htm | 10-Q | 985008
2 | EX-31.1 | d331981dex311.htm | EX-31.1 | 9863
3 | EX-31.2 | d331981dex312.htm | EX-31.2 | 9871
4 | EX-32 | d331981dex32.htm | EX-32 | 4821
| Complete submission text file | 0001193125-18-150803.txt |  | 7358202

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE DOCUMENT | teva-20180331.xml | EX-101.INS | 1540539
6 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20180331.xsd | EX-101.SCH | 92514
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20180331_cal.xml | EX-101.CAL | 99672
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20180331_def.xml | EX-101.DEF | 474280
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20180331_lab.xml | EX-101.LAB | 595690
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20180331_pre.xml | EX-101.PRE | 555813

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 18803808
SIC: 2834 Pharmaceutical Preparations